This inventor holds 2 USPTO granted patents and 2 EPO patents. Top assignee: Megafine Pharma (P) Ltd.. Active years: 2012-2015.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2012-2015
Title: Kunal Madhav Jagtap: Innovator in Pharmaceutical Chemistry
Introduction: Kunal Madhav Jagtap is a notable inventor based in Maharashtra, India. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of novel processes for drug preparation. With a total of two patents to his name, Jagtap's work is recognized for its innovative approaches to complex chemical processes.
Latest Patents: Jagtap's latest patents include a process for the preparation of bosentan, which involves a novel ammonium salt of bosentan. This process allows for the creation of either crystalline or amorphous forms of the salt. The method entails reacting 4,6-dichloro-5-(2-methoxyphenoxy)-2,2'-bipyrimidine with 4-tert-butylbenzenesulfonamide in the presence of a solvent and a base, followed by the addition of ethylene glycol to isolate the ammonium salt. Additionally, he has developed a method for the preparation of solifenacin, which involves reacting quinuclidin-3-ol with bis(aryl) carbonate to form a key intermediate used in the production of solifenacin base.
Career Highlights: Kunal Jagtap is currently employed at Megafine Pharma Pvt. Ltd., where he continues to innovate in the pharmaceutical sector. His work focuses on improving
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile